The Central Drugs Standard Control Organisation (CDSCO), India’s national regulatory body for pharmaceuticals and medical devices, has released its monthly report for October 2024, where it identified several batches of medicines as spurious. This critical regulatory alert is part of…
The Central Drugs Standard Control Organization (CDSCO) has released the “Not of Standard Quality” NSQ drugs alert for October 2024. This monthly update aims to inform stakeholders about pharmaceutical products that have failed to meet quality standards. It is an…
For pharmaceutical manufacturers in India, complying with Schedule M – the cornerstone of Good Manufacturing Practices (GMP) – has long been the game. But the winds of change have blown, ushering in a revised Schedule M, promising a more robust…
Tramadol Hydrochloride is a top pain-relieving medicine that is used in moderate to severe pain situations. However, there are lots of cases registered of misusing medicine in some states of India, it is a medication that can lead to addiction…